Plasma and tissue depletion of florfenicol and florfenicol-amine in chickens

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 22, 2008, Pages 11049-11056

  Anadón, Arturo ^a   Martínez, Maria Aranzazu ^a   Martínez, Marta ^a   Ríos, Alba ^a   Caballero, Virginia ^a   Ares, Irma ^a   Martínez Larrañaga, Maria Rosa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Chickens for fattening; Florfenicol; Plasma and tissue depletion; Withdrawal time

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; FLORFENICOL; FLORFENICOL AMINE; THIAMPHENICOL;

ANIMAL; ARTICLE; CHICKEN; FOOD CONTAMINATION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEAT; METABOLISM;

ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOOD CONTAMINATION; HALF-LIFE; MEAT; THIAMPHENICOL;

GALLUS GALLUS;

EID: 57849128975     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf802138y     Document Type: Article

References (46)

1. Cannon, M.; Harford, S.; Davies, J. A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. Antimicrob. Agents Chemother. 1990, 26, 307-317.
2. Shaw, W. V. Chloramphenicol acetyltransferase, enzymology and molecular biology. Crit. Rev. Biochem. 1983, 14, 1-46.
3. Murray, I. A.; Shaw, W. V. O-Acetyltransferases for chloramphenicol and other natural products. Antimicrob. Agents Chemother. 1997, 41, 1-6.
4. Neu, H. C.; Fu, K. P. In vitro activity of chloramphenicol and thiamphenicol analogs. Antimicrob. Agents Chemother. 1980, 18, 311-316.
5. Syriopoulou, V. P.; Harding, A. L.; Goldmann, D. A.; Smith, A. L. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob. Agents Chemother. 1981, 19, 294-297.
6. Yunis, A. A. Chloramphenicol: Relation of structure to activity and toxicity. Annu. Rev. Pharmacol. Toxicol. 1988, 28, 83-100.
7. Sams, R. A. Florfenicol: Chemistry and metabolism of a novel broad-spectrum antibiotic. Tieraerztl. Umschau 1995, 50, 703-707.
8. Graham, R.; Palmer, D.; Pratt, B. C.; Hart, C. A. In vitro activity of florfenicol. Eur. J. Clin. Microbiol. Infect. Dis. 1988, 7, 691-694.
9. Ueda, Y.; Suenaga, I. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae. J. Vet. Med. Sci. 1955, 57, 363-364.
10. Sams, R. A. Florfenicol: Chemistry and metabolism of a novel broad-spectrum antibiotic. In Proceedings of the 18th World Buiatrics Congress, Bologna, Italy, 1994; pp 13-17.
11. Anonymous. Florfenicol (Extension to chicken) - Summary report. In EMEA/MRL/589/99-FINAL, Committee for Veterinary Medicinal Products/The European Agency for the Evaluation of Medicinal Products, Canary Wharf, London, U.K., 1999; pp 1-3.
12. Nordmo, R.; Varma, K. J.; Sutherland, I. H.; Brokken, E. S. Florfenicol in Atlantic salmon, Salmo salar L.: Field evaluation of efficacy furunculosis in Norway. J. Fish Dis. 1994, 17, 239-244.
13. Booker, C. W.; Jim, G. K.; Guichon, P. T.; Schunicht, O. C.; Thorlakson, B. E.; Lockwood, P. W. Evaluation of florfenicol for the treatment of undifferentiated fever in feedlot calves in western Canada. Can. Vet. J. 1997, 38, 555-560.
14. Sheldon, I. M. A field trial of florfenicol for enteric disease in calves. Cattle Prod. 1997, 5, 195-198.
15. De Craene, B. A.; Deprez, P.; D'Haese, E.; Nelis, H. J.; van den Bossche, W.; De Leenheer, A. P. Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves. Antimicrob. Agents Chemother. 1997, 41, 1991-1995.
16. El-Banna, H. A. Pharmacokinetics of florfenicol in normal and Pasteurella-infected Muscovy ducks. Br. Poult. Sci. 1998, 39, 492-496.
17. Liu, J.; Fung, K. F.; Chen, Z.; Zeng, Z.; Zhang, J. Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae. Antimicrob. Agents Chemother. 2003, 47, 820-823.
18. Varma, K. J.; Adams, P. E.; Powers, T. E.; Powers, J. D.; Lamendola, J. F. Pharmacokinetics of florfenicol in veal calves. J. Vet. Pharmacol. Ther. 1986, 9, 412-425.
19. Adams, P. E.; Varma, K. J.; Powers, T. E.; Lamendola, J. F. Tissue concentrations and pharmacokinetics of florfenicol in male veal calves given repeated doses. Am. J. Vet. Res. 1987, 48, 1725-1732.
20. Lobell, R. D.; Varma, K. J.; Johnson, J. C.; Sams, R. A.; Gerken, D. F.; Ashcraft, S. M. Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J. Vet. Pharmacol. Ther. 1994, 17, 253-258.
21. Bretzlaff, K. N.; Neff-Davis, C. A.; Ott, R. S.; Koritz, G. D.; Gustafsson, B. K.; Davis, L. E. Florfenicol in non-lactating dairy cows: Pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils. J. Vet. Pharmacol. Ther. 1987, 10, 233-240.
22. Soback, S.; Paape, M. J.; Filep, R.; Varma, K. J. Florfenicol pharmacokinetics in lactating cows after intravenous, intramuscular and intramammary administration. J. Vet. Pharmacol. Ther. 1995, 18, 413-417.
23. McKellar, Q. A.; Varma, K. J. Pharmacokinetics and tolerance of florfenicol in equidae. Equine Vet. J. 1996, 28, 209-213.
24. Lavy, E.; Ziv, G.; Soback, S.; Glickman, A.; Winkler, M. Clinical pharmacology of florfenicol in lactating goats. Acta Vet. Scand. 1991, 87 (Supplement), 133-136.
25. Voorspoels, J.; D'Haese, E.; De Craene, B. A.; Vervaet, C.; De Riemaecker, D.; Deprez, P.; Nelis, H.; Remon, J. P. Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days. Vet. Rec. 1999, 145, 397-399.
26. Jiang, H.; Zeng, Z.-L.; Chen, Z.-L.; Liu, J. J.; Fung, K.-F. Pharmacokinetics of florfenicol in pigs following intravenous, intramuscular or oral administration and the effects of feed intake on oral dosing. J. Vet. Pharmacol. Ther. 2006, 29, 153-156.
27. Jianzhong, S.; Xiubo, L.; Haiyang, J.; Walter, H. H. Bioavailability and pharmacokinetics of florfenicol in healthy sheep. J. Vet. Pharmacol. Ther. 2004, 27, 163-168.
28. Lane, U. M.; Villarroel, A.; Wetzlich, S. E.; Clifford, A.; Taylor, I.; Craigmill, A. L. Intravenous and subcutaneous pharmacokinetics of florfenicol in sheep. J. Vet. Pharmacol. Ther. 2004, 27, 191-196.
29. Afifi, N. A.; El-Sooud, K. A. Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens. Br. Poult. Sci. 1997, 38, 425-428.
30. Shen, J.; Wu, X.; Hu, D.; Jiang, H. Pharmacokinetics of florfenicol in healthy and Escherichia coli-infected broiler chickens. Res. Vet. Sci. 2002, 73, 137-140.
31. Shen, J.; Hu, D.; Wu, X.; Coats, J. R. Bioavailability and pharmacokinetics of florfenicol in broiler chickens. J. Vet. Pharmacol. Ther. 2003, 26, 337-341.
32. Martínez-Larrañaga, M. R.; Rios, A.; Martínez, M. A.; Martínez, M.; Isea, G.; Anadón, A. Oral bioavailability of florfenicol and its metabolite florfenicol amine in chickens. In 9th International EAVPT Congress, Lisboa, Portugal, July 13-18, 2003. Abstract in J. Vet. Pharmacol. Ther. 2003, 26 (Supplement 1), 115.
33. Martínez, M. A.; Rios, A.; Martínez, M.; Caballero, V.; Ares, I.; Castellano, V.; Diaz, M. J.; Martínez-Larrañaga, M. R.; Anadón, A. Tissue distribution and depletion of florfenicol in chickens. In 10th International EAVPT Congress, Torino, Italy, Sept 17-22, 2006. Abstract in J. Vet. Pharmacol. Ther. 2006, 29 (Supplement 1), 155.
34. Anonymous. Florfenicol (extension to all food producing species) - Summary report. In EMEA/MRL/822/902-FINAL, Committee for Veterinary Medicinal Products/The European Agency for the Evaluation of Medicinal Products, Canary Wharf, London, U.K., 2002; pp 1-2.
35. Sanderson, D. M. A note on glycerol formal as a solvent in toxicity testing. J. Pharm. Pharmacol. 1959, 11, 150-156.
36. Anonymous. Guideline on validation of analytical procedures: Methodology (VICH GL2). In CVMP/VICH/591/98-FINAL, Committee for Veterinary Medicinal Products/The European Agency for the Evaluation of Medicinal Products, Canary Wharf, London, U.K., 1998; pp 1-10.
37. Yamaoka, K.; Nakagawa, T.; Uno, T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 1978, 6, 165-175.
38. Wagner, J. G. Fundamentals of Clinical Pharmacokinetics, 1st ed.; Drug Intelligence Publications: Hamilton, IL, 1975.
39. Wagner, J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J. Pharmacokinet. Biopharm. 1976, 4, 443-467.
40. Anonymous. Updated Application Software relating to Note for Guidance on Approach towards Harmonisation of Withdrawal Periods for Meat. In EMEA/CVMP/563/02, Committee for Veterinary Medicinal Products/The European Agency for the Evaluation of Medicinal Products, Canary Wharf, London, U.K., 2002; p 1.
41. Schwartz, S.; Kehrenberg, C.; Doublet, B.; Cloeckaert, A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 2004, 28, 519-542.
42. Hyatt, J. M.; Mckinnon, P. S.; Zimmer, G. S.; Schentag, J. J. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clin. Pharmacokinet. 1995, 28, 143-160.
43. Lees, P.; Aliabadi, F. S. Rational dosing of antimicrobial drugs: Animals versus humans. Int. J. Antimicrob. Agents 2002, 19, 269-284.
44. Craig, M. A. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 1998, 26, 1-12.
45. Inglis, V.; Richards, R. H. The in vitro susceptibility of Aeromonas salmonicida and other fish-pathogenic bacteria to 29 antimicrobial agents. J. Fish Dis. 1991, 14, 641-650.
46. Priebe, S.; Schwarz, S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob. Agents Chemother. 2003, 47, 2703-2705.